Skip to main content

Advertisement

Log in

Long-term outcomes after an aggressive resection of adenosquamous carcinoma of the pancreas

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

Adenosquamous carcinoma (ASC) of the pancreas is a rare malignancy, associated with a poor prognosis after surgical resection, with reported median survival times (MSTs) ranging from 4.4 to 13.1 months. We conducted this study to investigate the long-term outcomes of patients after the resection for ASC.

Methods

Between 2002 and 2016, a total of 456 patients underwent resection for ASC or adenocarcinoma (AC) of the pancreas. ASC was confirmed in 17 (3.7%) of these patients. We analyzed the clinicopathological characteristics and survival of these 17 patients in comparison with those of patients with AC of the pancreas.

Results

The operative procedures performed were pancreaticoduodenectomy (n = 6) and distal pancreatectomy (n = 11). Seven (41.2%) of the 17 patients underwent combined organ resection. R0 resection was achieved in 16 (94.1%) patients. The 5-year overall survival (OS) rate and MST were 40.3% and 20.9 months, respectively. A squamous component of ≥ 60% (P = 0.001) and R1 resection (P < 0.001) were significantly associated with poor OS for patients with ASC

Conclusion

This study revealed longer survival and a higher R0 resection rate after aggressive combined resection in our ASC patients than those in previous studies. Although this was only a small series, our findings suggest that local control with aggressive resection may be an effective treatment protocol for ASC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Capussotti L, Massucco P, Ribero D, Vigano L, Muratore A, Calgaro M (2003) Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg 138:1316–1322

    Article  PubMed  Google Scholar 

  2. Wray CJ, Ahmad SA, Matthews JB, Lowy AM. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology. 2005;128:1626–41.

    Article  PubMed  Google Scholar 

  3. Yamada S, Fujii T, Sugimoto H, Nomoto S, Takeda S, Kodera Y, et al. Aggressive surgery for borderline resectable pancreatic cancer: evaluation of National Comprehensive Cancer Network guidelines. Pancreas. 2013;42:1004–100.

    Article  PubMed  Google Scholar 

  4. Katz MH, Taylor TH, Al-Refaie WB, Hanna MH, Imagawa DK, Anton-Culver H, et al. Adenosquamous versus adenocarcinoma of the pancreas: a population-based outcomes analysis. J Gastrointest Surg. 2011;15:165–74.

    Article  PubMed  Google Scholar 

  5. Boyd CA, Benarroch-Gampel J, Sheffield KM, Cooksley CD, Riall TS. 415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival. J Surg Res. 2012;174:12–9.

    Article  PubMed  Google Scholar 

  6. Madura JA, Jarman BT, Doherty MG, Yum MN, Howard TJ (1999) Adenosquamous carcinoma of the pancreas. Arch Surg. 134:599–603

    Article  CAS  PubMed  Google Scholar 

  7. Hsu JT, Chen HM, Wu RC, Yeh CN, Yeh TS, Hwang TL, et al. Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma. World J Surg Oncol. 2008;6:95.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Smoot RL, Zhang L, Sebo TJ, Que FG. Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care. J Am Coll Surg. 2008;207:368–70.

    Article  PubMed  Google Scholar 

  9. Voong KR, Davison J, Pawlik TM, Uy MO, Hsu CC, Winter J, et al. Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients. Hum Pathol. 2010;41:113–22.

    Article  CAS  PubMed  Google Scholar 

  10. Simone CG, Zuluaga Toro T, Chan E, Feely MM, Trevino JG, George TJ Jr. Characteristics and outcomes of adenosquamous carcinoma of the pancreas. Gastrointestinal cancer research : GCR. 2013;6:75–9.

    PubMed  Google Scholar 

  11. Kardon DE, Thompson LD, Przygodzki RM, Heffess CS. Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases. Gastrointest Cancer Res GCR. 2001; 14:443-51.

  12. Hester CA, Augustine MM, Choti MA, Mansour JC, Minter RM, Polanco PM, et al. Comparative outcomes of adenosquamous carcinoma of the pancreas: an analysis of the National Cancer Database. J Surg Oncol. 2018;118:21–30.

    Article  PubMed  Google Scholar 

  13. Yamamoto T, Sugiura T, Mizuno T, Okamura Y, Aramaki T, Endo M, et al. Preoperative FDG-PET predicts early recurrence and a poor prognosis after resection of pancreatic adenocarcinoma. Ann Surg Oncol. 2015;22:677–84.

    Article  PubMed  Google Scholar 

  14. Ito T, Sugiura T, Okamura Y, Yamamoto Y, Ashida R, Aramaki T et al (2017) The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer. Pancreatology. 17:451–456

    Article  PubMed  Google Scholar 

  15. Sugiura T, Okamura Y, Ito T, Yamamoto Y, Uesaka K. Surgical indications of distal pancreatectomy with celiac axis resection for pancreatic body/tail cancer. World J Surg. 2017;41:258–66.

    Article  PubMed  Google Scholar 

  16. Sugiura T, Uesaka K, Mihara K, Sasaki K, Kanemoto H, Mizuno T, et al. Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer. Surgery. 2013;154:1078–86.

    Article  PubMed  Google Scholar 

  17. Sobin L, Gospodarowicz M, Wittekind C (2009) TNM classification of malignant tumors, 7th edn. Wiley, New York

    Google Scholar 

  18. Hoshimoto S, Hoshi N, Hishinuma S, Shirakawa H, Tomikawa M, Ozawa I et al (2017) Clinical implications of the proliferative ability of the squamous component regarding tumor progression of adenosquamous carcinoma of the pancreas: a preliminary report. Pancreatology. 17:788–794

    Article  PubMed  Google Scholar 

  19. Solaini L, de Rooij T, Marsman EM, Te Riele WW, Tanis PJ, van Gulik TM, et al. Pancreatoduodenectomy with colon resection for pancreatic cancer: a systematic review. HPB. 2018;20:881–7.

    Article  PubMed  Google Scholar 

  20. Hong SM, Kim MJ, Jang KT, Yoon GS, Cho H, Frierson HF, et al. Adenosquamous carcinoma of extrahepatic bile duct: clinicopathologic study of 12 cases. Int J Clin Exp Pathol. 2008;1:147–56.

    PubMed Central  PubMed  Google Scholar 

  21. Komatsu H, Egawa S, Motoi F, Morikawa T, Sakata N, Naitoh T, et al. Clinicopathological features and surgical outcomes of adenosquamous carcinoma of the pancreas: a retrospective analysis of patients with resectable stage tumors. Surg Today. 2015;45:297–304.

    Article  PubMed  Google Scholar 

  22. Imaoka H, Shimizu Y, Mizuno N, Hara K, Hijioka S, Tajika M et al (2014) Ring-enhancement pattern on contrast-enhanced CT predicts adenosquamous carcinoma of the pancreas: a matched case–control study. Pancreatology. 14:221–226

    Article  PubMed  Google Scholar 

  23. Toshima F, Inoue D, Yoshida K, Yoneda N, Minami T, Kobayashi S, et al. Adenosquamous carcinoma of pancreas: CT and MR imaging features in eight patients, with pathologic correlations and comparison with adenocarcinoma of pancreas. Abdom Radiol (New York). 2016;41:508–20.

    Article  Google Scholar 

  24. Okabayashi T, Hanazaki K. Surgical outcome of adenosquamous carcinoma of the pancreas. World J Gastroenterol. 2008;14:6765–70.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K et al (2007) Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. Jama. 297:267–277

    Article  CAS  PubMed  Google Scholar 

  26. Oettle H, Neuhaus P, Hochhaus A, Hartmann JT, Gellert K, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. Jama. 2013;310:1473–81.

    Article  CAS  PubMed  Google Scholar 

  27. Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, et al. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet (London, England). 2016;388:248–57.

    Article  CAS  Google Scholar 

  28. Yamaguchi K, Okusaka T, Shimizu K, Furuse J, Ito Y, Hanada K, et al. Clinical practice guidelines for pancreatic cancer 2016 from the Japan Pancreas Society: a synopsis. Pancreas. 2017;46:595–604.

    Article  PubMed  Google Scholar 

  29. Wild AT, Dholakia AS, Fan KY, Kumar R, Moningi S, Rosati LM, et al. Efficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous carcinoma of the pancreas. J Gastrointest Oncol. 2015;6:115–25.

    PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takaaki Ito.

Ethics declarations

Conflict of interest

Takaaki Ito and his co-authors have no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ito, T., Sugiura, T., Okamura, Y. et al. Long-term outcomes after an aggressive resection of adenosquamous carcinoma of the pancreas. Surg Today 49, 809–819 (2019). https://doi.org/10.1007/s00595-019-01807-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-019-01807-8

Keywords

Navigation